The manuscript “Effectiveness and Safety of Early Rhythm Control in Patients with Atrial Fibrillation and Chronic Kidney Disease” has been published in the Journal of the American College of Cardiology (JACC).
Once again, four young scientists were honored with the AFNET-sponsored “DGK AFNET Young Investigator Award” for their current research on atrial fibrillation. AFNET Board Member and this year’s DGK Conference President Prof. Dr. Stephan Willems congratulated the award recipients during the award ceremony on April 10, 2026 at the DGK Annual Congress.
As part of the “23 Years of AFNET” session, Prof. Steinbeck presented the AFNET Lecture titled “EP Studies Revisited.” For his long-standing commitment, he received this year’s DGK-AFNET Lecture Award, which was presented for the third time. Prof. Sinner presented the results of the 10th AFNET-EHRA Consensus Conference.
Once again AFNET was present at the 2026 DGK Annual Meeting with a wide range of presentations and events.
At the EHRA 2026 Congress in Paris on 13 April 2026, Prof. Dr. Andreas Götte presented the results of “Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.”
The current EAST-AFNET 4 manuscript was accepted for publication in the ‘JAMA Cardiology’ journal.
The entire MAESTRIA – AFNET 10 team is looking forward to welcoming study sites in Madrid on 30th of August.
Prof Camm was honoured with the AFNET Lecture Award at the AFNET general meeting during the DGK 2025 annual conference in Mannheim. In this document you can see his lecture at the award ceremony.
The MAESTRIA Consortium, which consists of 18 partners from different European countries, met for the 3rd time on 8 and 9 May to discuss the progress of the EU-funded MAESTRIA project.
Prof. Dr. med. Götz Thomalla (UKE) and Dr. med. Märit Jensen (UKE) have recorded a video on the new EAST-STROKE trial in layman’s terms.
The EAST-STROKE (‘Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE’) trial is led by scientist from the University Medical Centre Hamburg-Eppendorf (UKE) and investigates whether early rhythm-control treatment can effectively and safely prevent strokes. The project is funded by the EU as part of ‘Horizon Europe’. AFNET is partner for dissemination and exploitation.
